Treatment of respiratory syncytial virus infection in adult patients with hematologic malignancies based on an institution-specific guideline.

@article{McCoy2011TreatmentOR,
  title={Treatment of respiratory syncytial virus infection in adult patients with hematologic malignancies based on an institution-specific guideline.},
  author={Dorothy McCoy and Emily K Wong and Arpi G Kuyumjian and Michael A Wynd and Rani Sebti and Gary Munk},
  journal={Transplant infectious disease : an official journal of the Transplantation Society},
  year={2011},
  volume={13 2},
  pages={117-21}
}
A total of 26 adults with hematologic malignancies and/or hematopoietic stem cell transplant were treated for respiratory syncytial virus (RSV) infection based on an institutional guideline. Thirteen patients received aerosolized ribavirin, and 13 received aerosolized ribavirin and intravenous palivizumab. Two deaths, not attributed to RSV infection… CONTINUE READING